Genetics

  • A Stanford study shows that using genomes from a diverse pool of people improves the ability to predict an individual’s risk of having high cholesterol.

  • Pathology faculty net four NIH grants

    Efforts to design a hepatitis C vaccine, understand the genetic causes of rare diseases, map genetic regulatory elements in organ systems and understand coronavirus immune responses garner over $40 million.

  • Grants for genome research

    Five Stanford researchers will participate in a $180 million nationwide campaign by the National Institutes of Health to understand the effect of human-genome variations on health and disease.

  • Common genetic profile linked to drug reaction

    New medications help many people with inflammatory conditions and may ease severe COVID-19, but they carry risks.

  • Breast cancer mutations don’t lower survival rates

    Newly diagnosed breast or ovarian cancer patients who carry common cancer-associated mutations have similar or better short-term survival rates than those with no mutations, researchers report.

  • Statins could treat ulcerative colitis

    People with ulcerative colitis who are also taking statins have about a 50% decreased risk of colectomies and hospitalization, according to a Stanford Medicine study.

  • Genetics of cat color patterns

    Researchers discovered some of the genetics behind cat coloring, from Abyssinians and tabbies to leopards and tigers.

  • Old skeletal stem cells hinder healing

    Researchers have found that old skeletal stem cells contribute to bone fragility and poor healing in mice, but that a stem cell-boosting gel may help restore function.

  • Cryptography can preserve genetic privacy

    Crime scene DNA analysis can help identify perpetrators, but current methods may divulge the genetic information of innocent people. Cryptography can protect genetic privacy without hampering law enforcement, Stanford researchers say.

  • Health Matters to explore medicine, wellness

    Stanford Medicine's free community event, which runs May 10-15, will include talks and Q&As that explore the latest advances in medicine, health and wellness.

  • Making medicine out of RNA

    Ribonucleic acid, a key player in cellular protein production, is used, with increasing success, by biotechnologists bent on preventing and curing diseases.

  • Genome sequencing at Stanford Health Care

    Stanford Medicine now provides a service that harnesses the power of genome sequencing to identify the source of diseases and help target treatments.


Related Websites